Market Overview:
The global oseltamivir phosphate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for oseltamivir phosphate from various applications such as antibiotics, pharmaceutical intermediates, and pharmaceutical raw materials. Additionally, the growing population and rising income levels are also contributing to the growth of this market. However, factors such as stringent regulatory norms and high costs associated with R&D are restraining the growth of this market.
Product Definition:
Oseltamivir phosphate is a neuraminidase inhibitor that is used to prevent and treat seasonal and pandemic influenza A virus infections.
Purity >99.0%:
Purity >99.0%, it's usage.
Oseltamivir phosphate is a prescription drug used to treat influenza infections, the common cold, and shingles (herpes zoster). It is also used as an antiviral medication for patients with AIDS. The drug has no significant side effects; however, there are some rare cases of liver damage associated with its administration.
Purity
Oseltamivir phosphate is a prescription medicine used to treat influenza (flu) viruses. Flu viruses are found in animals, plants, and bacteria. They can cause infections in the lungs and other parts of the body. The most common symptoms of flu are fever, cough, headache, sore throat and runny nose; muscle ache; pains in the bones or joints; diarrhea; vomiting; fatigue; shivering or sweatiness etc.
Application Insights:
The global oseltamivir phosphate market is segmented on the basis of application into antibiotic, pharmaceutical intermediates and pharmaceutical raw materials. The antibiotic application segment dominated the overall industry in terms of revenue share in 2017. This high share is attributable to extensive usage as an anti-influenza agent and for treatment of different bacterial infections.
Oseltamivir phosphate has a broad spectrum activity against influenza A & B viruses; it exhibits good antiviral activity against both Type A (H1N1) and Type B strains with similar efficacy as that observed for zanamivir, another Oseltamviper product.
Regional Analysis:
North America was the leading revenue contributor in 2017. The region is anticipated to maintain its dominance during the forecast period on account of rising product demand for treatment and prevention of influenza. In addition, presence of key manufacturers such as Gilead Sciences, Inc.; FMC Corporation; and AbbVie Inc., in this region is expected to propel market growth over the forecast period.
Asia Pacific oseltamivir phosphate market is expected to witness significant growth over the projected period owing to increasing prevalence of COVID-19 positive cases coupled with government support for new drug development programs. Presence of a large number of generic drug manufacturers has resulted in low price competition among these companies which are further likely to drive regional market growth during the estimated time span.
Growth Factors:
- Increasing incidence of seasonal and pandemic flu
- Growing awareness about the benefits of oseltamivir phosphate
- Rising demand for antiviral drugs to treat influenza infections
- Proliferation of retail pharmacies and drug stores across the globe
- Availability of generic versions of oseltamivir phosphate
Scope Of The Report
Report Attributes
Report Details
Report Title
Oseltamivir Phosphate Market Research Report
By Type
Purity >99.0%, Purity <99.0%
By Application
Antibiotic, Pharmaceutical Intermediates, Pharmaceutical Raw Materials
By Companies
Cayman Chemical, TRC, BOC Sciences, Combi-Blocks, Santa Cruz Biotechnology, MedKoo, AbMole BioScience, Active Biopharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oseltamivir Phosphate Market Report Segments:
The global Oseltamivir Phosphate market is segmented on the basis of:
Types
Purity >99.0%, Purity <99.0%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antibiotic, Pharmaceutical Intermediates, Pharmaceutical Raw Materials
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cayman Chemical
- TRC
- BOC Sciences
- Combi-Blocks
- Santa Cruz Biotechnology
- MedKoo
- AbMole BioScience
- Active Biopharma
Highlights of The Oseltamivir Phosphate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity >99.0%
- Purity <99.0%
- By Application:
- Antibiotic
- Pharmaceutical Intermediates
- Pharmaceutical Raw Materials
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oseltamivir Phosphate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oseltamivir phosphate is an antiviral medication used to treat the flu. It works by stopping the virus from replicating in your body.
Some of the key players operating in the oseltamivir phosphate market are Cayman Chemical, TRC, BOC Sciences, Combi-Blocks, Santa Cruz Biotechnology, MedKoo, AbMole BioScience, Active Biopharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oseltamivir Phosphate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oseltamivir Phosphate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oseltamivir Phosphate Market - Supply Chain
4.5. Global Oseltamivir Phosphate Market Forecast
4.5.1. Oseltamivir Phosphate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oseltamivir Phosphate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oseltamivir Phosphate Market Absolute $ Opportunity
5. Global Oseltamivir Phosphate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oseltamivir Phosphate Market Size and Volume Forecast by Type
5.3.1. Purity >99.0%
5.3.2. Purity <99.0%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oseltamivir Phosphate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oseltamivir Phosphate Market Size and Volume Forecast by Application
6.3.1. Antibiotic
6.3.2. Pharmaceutical Intermediates
6.3.3. Pharmaceutical Raw Materials
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oseltamivir Phosphate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oseltamivir Phosphate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oseltamivir Phosphate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oseltamivir Phosphate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oseltamivir Phosphate Demand Share Forecast, 2019-2026
9. North America Oseltamivir Phosphate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oseltamivir Phosphate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oseltamivir Phosphate Market Size and Volume Forecast by Application
9.4.1. Antibiotic
9.4.2. Pharmaceutical Intermediates
9.4.3. Pharmaceutical Raw Materials
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oseltamivir Phosphate Market Size and Volume Forecast by Type
9.7.1. Purity >99.0%
9.7.2. Purity <99.0%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oseltamivir Phosphate Demand Share Forecast, 2019-2026
10. Latin America Oseltamivir Phosphate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oseltamivir Phosphate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oseltamivir Phosphate Market Size and Volume Forecast by Application
10.4.1. Antibiotic
10.4.2. Pharmaceutical Intermediates
10.4.3. Pharmaceutical Raw Materials
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oseltamivir Phosphate Market Size and Volume Forecast by Type
10.7.1. Purity >99.0%
10.7.2. Purity <99.0%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oseltamivir Phosphate Demand Share Forecast, 2019-2026
11. Europe Oseltamivir Phosphate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oseltamivir Phosphate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oseltamivir Phosphate Market Size and Volume Forecast by Application
11.4.1. Antibiotic
11.4.2. Pharmaceutical Intermediates
11.4.3. Pharmaceutical Raw Materials
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oseltamivir Phosphate Market Size and Volume Forecast by Type
11.7.1. Purity >99.0%
11.7.2. Purity <99.0%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Grwth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oseltamivir Phosphate Demand Share, 2019-2026
12. Asia Pacific Oseltamivir Phosphate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oseltamivir Phosphate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oseltamivir Phosphate Market Size and Volume Forecast by Application
12.4.1. Antibiotic
12.4.2. Pharmaceutical Intermediates
12.4.3. Pharmaceutical Raw Materials
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oseltamivir Phosphate Market Size and Volume Forecast by Type
12.7.1. Purity >99.0%
12.7.2. Purity <99.0%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oseltamivir Phosphate Demand Share, 2019-2026
13. Middle East & Africa Oseltamivir Phosphate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oseltamivir Phosphate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oseltamivir Phosphate Market Size and Volume Forecast by Application
13.4.1. Antibiotic
13.4.2. Pharmaceutical Intermediates
13.4.3. Pharmaceutical Raw Materials
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oseltamivir Phosphate Market Size and Volume Forecast by Type
13.7.1. Purity >99.0%
13.7.2. Purity <99.0%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oseltamivir Phosphate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oseltamivir Phosphate Market: Market Share Analysis
14.2. Oseltamivir Phosphate Distributors and Customers
14.3. Oseltamivir Phosphate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cayman Chemical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. TRC
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BOC Sciences
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Combi-Blocks
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santa Cruz Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MedKoo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. AbMole BioScience
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Active Biopharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
